Search

Search Results

1. Macular lesions associated with age-related macular degeneration in pachydrusen eyes

   Background

   To investigate the prevalence of macular lesions associated with age-related macular degeneration (AMD) in eyes with pachydrusen.

   ...

   Seung Wan Nam, Hoon Noh, ... Don-Il Ham in Eye

   Article 29 September 2023
   

2. Volume-rendering three-dimensional image analysis of macular neovascularization in age-related macular degeneration

   Background

   To visualize and investigate the three-dimensional (3D) images of macular neovascularization (MNV) in eyes with neovascular age-related...

   Mihyun Choi, Sangheon Han, ... Jaeryung Oh in Eye

   Article 01 December 2023
   

3. Serum adropin level in wet-type age-related macular degeneration

   Purpose

   Our objective was to compare the serum Adropin levels between patients with wet-type Age-Related Macular Degeneration (AMD) and otherwise...

   Zahra Saeedi-Maleki, Alireza Javadzadeh, ... Farideh Mousavi in International Journal of Retina and Vitreous

   Article Open access 12 March 2024

4. Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration

   Background

   Significant diurnal fluctuation of optical coherence tomography (OCT)-based macular fluid occurs in patients with several macular...

   Blake H. Fortes, Aaron M. Fairbanks, ... Andrew J. Barkmeier in International Journal of Retina and Vitreous

   Article Open access 25 September 2023
   

5. Tyrosine Kinase Inhibitors and their role in treating neovascular age-related macular degeneration and diabetic macular oedema

   The advent of intravitreal anti-VEGF injections has revolutionised the treatment of both neovascular age-related macular degeneration (nAMD or wet...

   Shruti Chandra, Emanuel Yuquan Tan, ... Sobha Sivaprasad in Eye

   Article 07 June 2023
   

6. Mast cells in human choroid and their role in age-related macular degeneration (AMD)

   The role of mast cells in physiologic and pathological processes extends far beyond the allergy processes: they are involved in wound healing,...

   Domenico Ribatti, Rosanna Dammacco in Clinical and Experimental Medicine

   Article Open access 10 May 2024

7. Optical Coherence Tomography Angiography: A 2023 Focused Update on Age-Related Macular Degeneration

   Optical coherence tomography angiography (OCTA) has extensively enhanced our comprehension of eye microcirculation and of its associated diseases. In...

   Beatrice Tombolini, Emanuele Crincoli, ... Giuseppe Querques in Ophthalmology and Therapy

   Article Open access 05 January 2024
   

8. Anti-VEGF Drugs in Age-Related Macular Degeneration: A Focus on Dosing Regimen-Related Safety and Efficacy

   Age-related macular degeneration (AMD) is one of the main causes of visual impairment and severe visual loss, and can progress to two advanced...

   Haibei Ma, Hai Wei, ... Bing Wang in Drugs & Aging

   Article 20 October 2023
   

9. Shedding Light on Photobiomodulation Therapy for Age-Related Macular Degeneration: A Narrative Review

   Background

   Photobiomodulation (PBM) relies on the pathophysiological mechanism whereby red to near-infrared light can target mitochondrial activity...

   Federico Fantaguzzi, Beatrice Tombolini, ... Giuseppe Querques in Ophthalmology and Therapy

   Article Open access 28 September 2023

10. Quantitative response of macular neovascularisation to loading phase of aflibercept in neovascular age-related macular degeneration

    Purpose

    To evaluate quantitative morphological changes in macular neovascularisation (MNV) network after aflibercept therapy in neovascular...

    Andrea Montesel, Ahmed M. Hagag, ... Sobha Sivaprasad in Eye

    Article 31 May 2023
    

11. Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy

    Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly, with dry AMD (d-AMD) leading to geographic atrophy (GA) and...

    Andrea Servillo, Riccardo Sacconi, ... Giuseppe Querques in Ophthalmology and Therapy

    Article Open access 04 June 2024
    

12. AI-based support for optical coherence tomography in age-related macular degeneration

    Artificial intelligence (AI) has emerged as a transformative technology across various fields, and its applications in the medical domain,...

    Virginia Mares, Marcio B. Nehemy, ... Ursula Schmidt-Erfurth in International Journal of Retina and Vitreous

    Article Open access 08 April 2024
    

13. Association of NLRPs with pathogenesis of dry age-related macular degeneration

    Background

    Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population, and Dry AMD is the most common clinical...

    Yiyun Zeng, Wentao Dong, ... Bolin Deng in International Ophthalmology

    Article 08 November 2023
    

14. Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes

    Intravitreal anti–vascular endothelial growth factor (VEGF) therapy is the standard of care for diabetic macular edema (DME) and neovascular...

    Hansjürgen Agostini, Francis Abreu, ... Peter D. Westenskow in Graefe's Archive for Clinical and Experimental Ophthalmology

    Article Open access 07 June 2024
    

15. Association between ambient air pollution and age-related macular degeneration: a meta-analysis

    Background

    Several epidemiological studies have investigated the association between ambient air pollution and age-related macular degeneration (AMD)....

    Jiali Wu, Yuzhu Zhang, **an Xu in BMC Ophthalmology

    Article Open access 30 April 2024
    

16. Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography

    Objectives

    To compare qualitative and quantitative features of type 1 macular neovascularizations (MNV) in pachychoroid neovasculopathy (PNV) and...

    Özge Yanık, Sibel Demirel, ... Emin Özmert in Eye

    Article Open access 12 March 2024
    

17. Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

    Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to...

    Eleonora M. Lad, Robert P. Finger, Robyn Guymer in Ophthalmology and Therapy

    Article Open access 29 September 2023
    

18. Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration

    Purpose

    To assess the short-term outcomes of intravitreal faricimab (IVF) for previously treated refractory neovascular age-related macular...

    Wissam Aljundi, Cristian Munteanu, ... Alaa Din Abdin in Graefe's Archive for Clinical and Experimental Ophthalmology

    Article 12 April 2024
    

19. Subclinical Angioid Streaks with Pseudodrusen: A New Phenotype of Age-Related Macular Degeneration

    Introduction

    To describe subclinical angioid streaks (AS) as a frequent, peculiar age-related macular degeneration (AMD) phenotype, comparing features...

    Riccardo Sacconi, Beatrice Tombolini, ... Giuseppe Querques in Ophthalmology and Therapy

    Article Open access 05 August 2023
    

20. Diagnostic accuracy of self-reported age-related macular degeneration in the ASPREE Longitudinal Study of Older Persons

    Background

    The validity of findings from epidemiological studies using self-report of ophthalmic conditions depends on several factors. We assessed...

    Myra B. McGuinness, Liubov Robman, ... Robyn H. Guymer in Eye

    Article Open access 20 September 2023